Trendlines Portfolio Companies Take Two "Best Start-up of the Year" Awards

TEL AVIV, Israel, June 27, 2013 /PRNewswire/ --

For the second year in a row, a Trendlines group portfolio company has won "Best Start-up of the Year," an award presented by the Office of the Chief Scientist in Israel. Last year, the Trendlines company Stimatix won the award.  This year Trendlines has done twice as well, with two portfolio companies receiving the award: One award was granted to ApiFix, of the Misgav Venture Accelerator, and the other to Sol Chip, of the Mofet Venture Accelerator. Both accelerators are owned by Trendlines and this double award is testimony to the investment group's unique mission to create and develop technology companies that improve the human condition.

Earlier this year, ApiFix received CE Mark for its minimally invasive treatment system for Adolescent Idiopathic Scoliosis (AIS). The revolutionary ApiFix AIS correction system minimizes risk, pain and scarring for the young patients for whom the device is targeted; and significantly speeds recovery time, and reduces costs.

Sol Chip, founded in 2009, has won its second award this year. In April, the company, which has developed a cost-effective, compact solar battery technology that integrates solar energy sources with low power electronic devices, won the Technological Development Award in the 2013 IDTechEx event held in Berlin, Germany. Sol Chip's patent-protected technology eliminates the need for a solar panel area and its miniaturized solution provides perpetual power for wireless sensor and mobile electronics.  

Todd Dollinger, CEO and Chairman, The Trendlines Group: "Of course, we are so proud of ApiFix and Sol Chip for receiving this honor.  Above and beyond the recognition the companies deserve, you can imagine the great joy and pride we feel that two of our portfolio companies have won this award this year - one from each of our incubators. It only confirms our mission and our method. "

About Trendlines

Trendlines (http://www.trendlines.com) creates and develops businesses to improve the human condition. Principally through its two Israeli government-licensed business incubators, Trendlines invests in innovation-based businesses in the areas of medtech and agritech, nurturing high-promise companies while mitigating seed-stage investment risk.

Media relations:
Efrat Kaduri  
Ofir Shpigel Media and Public Relations
+972-4-9535030

SOURCE Trendlines group